T1	Participants 91 184	patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase
T2	Participants 413 485	patients with newly diagnosed chronic myeloid leukemia in chronic phase.
T3	Participants 507 553	A total of 476 patients were randomly assigned
